Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
  1. 4 Open-market sale Director sold 510 shares at $38.53 ($19,648)
  2. 4 Grant or award Director acquired 6,400 shares (grant or award)
  3. 4 Grant or award Director acquired 3,200 shares (grant or award)
  4. 4 Grant or award Director acquired 3,200 shares (grant or award)
  5. 4 Grant or award Director acquired 3,200 shares (grant or award)
  6. 4 Grant or award Director acquired 3,200 shares (grant or award)
  7. 4 Grant or award Director acquired 3,200 shares (grant or award)
  8. 4 Grant or award Director acquired 3,200 shares (grant or award)
  9. 4 Open-market sale Chief Technical Ops Officer sold 64 shares at $41.16 ($2,634)
  10. 4 Open-market sale Chief Financial Officer sold 173 shares at $41.16 ($7,121)
  11. 4 Open-market sale Chief Business Officer sold 806 shares at $41.16 ($33,177)
  12. 4 Open-market sale Chief Executive Officer sold 378 shares at $41.16 ($15,559)
  13. 4 Open-market sale Exec. VP and CLO sold 3,363 shares at $45.01 ($151,375)
  14. 4 Open-market sale Director sold 1,650 shares at $40.06 ($66,094)
  15. 4 Open-market sale Exec. VP and CLO sold 9,234 shares at an average $45.19 ($417,274)
  16. 4 Grant or award Director acquired 2,613 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award Chief Executive Officer acquired 6,240 shares (grant or award)
  19. 4 Open-market sale Director sold 365 shares at $41.89 ($15,288)
  20. 4 Open-market sale Chief Business Officer sold 786 shares at $48.17 ($37,860)

Page 15 of 31 · 618 filings